
IceCure Medical Schedules First-Half 2026 Earnings Call
Caesarea-based IceCure Medical will release its financial and operational results for the first six months of 2026 on August 12. The company, which specializes in minimally invasive cryoablation technology for tumor destruction, plans to host a conference call and webcast to review these figures before the Nasdaq market opens.



























